Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites - Wikidata - awgldk - TriplyDB

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

http://www.wikidata.org/entity/Q34540211

about

Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.High yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays.Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection Activated Brain Endothelial Cells Cross-Present Malaria Antigen Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome.Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection From Clinical Malaria.Patterns of protective associations differ for antibodies to P.falciparum-infected erythrocytes and merozoites in immunity against malaria in children.An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites.Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets.

P2860

Q31139546-A86ED468-7D30-48B3-9D59-1D0B3C99544B Q31169310-07F3C0AC-FDCB-4850-86BB-BFDC84F5AF1E Q34443423-6D038958-5356-4F4B-BFAB-C7D67994515A Q34687174-42910820-0373-4534-8A50-4DA58E739F5F Q35654132-26CA3EA4-64B1-47D9-BDC6-1BE68C7DDFB6 Q36064542-063991BD-3384-4963-A9A6-6361FDD13C57 Q37129892-B034B417-D001-4A8E-8E9F-74858A872BC2 Q37496763-FABCB6F4-F35F-41DA-8B57-CE7D65A1C5E0 Q37530299-20FE8B98-D9D6-47DB-B9F3-3A7374E7A056 Q38945108-1DA8A484-75E4-438C-932B-06AC64509430 Q40073901-070B5522-BBF6-4B6A-9A16-9551AADE2D54 Q40438040-E595E135-134B-4CF9-855D-54A95C8B4925 Q47396685-36067023-CF87-457C-B2E3-8C9D199E1576

P2860

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

http://www.wikidata.org/entity/Q34540211

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@ast

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@en

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@nl

type

label

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@ast

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@en

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@nl

prefLabel

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@ast

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@en

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@nl

P1433

Q34540211-AA719C7C-218E-4BB4-92AD-49D268F07ED2

P1476

Q34540211-D1D0F9C8-C5AF-4F77-9525-BF080AAB7B7F

P2093

Q34540211-0DADA93E-ED61-408F-9D7F-4CBA166910FF

Q34540211-99F27649-A480-411E-9944-163A7A539DEA

Q34540211-9D517FDE-1281-42F7-A20C-A5EB74EE2A80

P2860

Q34540211-021A2026-6289-47E4-A1DB-002689F6C267

Q34540211-04862F16-2F79-4E78-9F86-B59F4E7BDA9D

Q34540211-09F37CF8-5387-470A-9F6E-003CDF515101

Q34540211-0E1E4BDB-8D77-4E4E-B76E-C670EC271326

Q34540211-10C1E03F-EC33-40C1-9B2E-48732E40910A

Q34540211-14313D82-DF39-4CC9-B9C8-C2B15998E2E2

Q34540211-14AC2794-7DAF-4516-9A34-2BDB7F8B8B39

Q34540211-14DAACA3-181E-4551-9E4A-BB6B8501A44B

Q34540211-15DC84DB-FD46-4BA5-B6C5-F0A447BFB629

Q34540211-1D55797A-D69E-4A70-A3B1-4878E5123029

P304

Q34540211-B2B6875B-4AD0-4B4A-A006-7B45103689C9

P31

Q34540211-52859CF7-FE63-4C22-9E40-9E50EE75299D

P356

Q34540211-D58E77C6-F0E2-43AB-9704-C002703746D7

P407

Q34540211-88EEED9C-6267-4F2B-A416-4546DFEE67EB

P433

Q34540211-64DB90A8-1C58-40B0-8FD0-FF0A758380CE

P478

Q34540211-B1EA5795-3B81-46B1-A078-18E0EE813993

P50

Q34540211-506DE929-1D14-4132-95F0-367C0F3679C5

Q34540211-C9B65B1D-0F9C-45E0-99BA-9149B12E4886

Q34540211-D4FAB981-E1C3-43A8-9C3C-65A5BD9FC330

Q34540211-EC221004-CDF7-447A-8FE0-0009B8787C35

P577

Q34540211-A7CB71B8-60F3-496E-9FB0-785A14F9E13F

P5875

Q34540211-57869A8E-81CE-45F1-B9E6-C53952792046

P698

Q34540211-79EAFEC1-54CB-4F7B-8863-74C398D6E32B

P921

Q34540211-4E4A00B5-B7BB-45FF-B2AB-9B63F3598A91

Q34540211-D429E563-0138-4129-ABCC-A12652CEE198

P932

Q34540211-D36B7D90-2794-4AD5-B307-F17F48756DEB

P356

JOURNAL.PONE.0051692

P1433

P1476

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites

@en

P2093

Amandine B Carmagnac

http://www.w3.org/2001/XMLSchema#string

Diana S Hansen

http://www.w3.org/2001/XMLSchema#string

Emily M Eriksson

http://www.w3.org/2001/XMLSchema#string

P2860

A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum

A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720

Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.

The importance of human FcgammaRI in mediating protection to malaria.

A numerical analysis model for interpretation of flow cytometric studies of ex vivo phagocytosis.

Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children

The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies

P304

e51692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0051692

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Alan Frederick Cowman

Louis Schofield

P577

2012-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234090155

http://www.w3.org/2001/XMLSchema#string

P698

23300556

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

3530572

http://www.w3.org/2001/XMLSchema#string